Interleukin 17 as a therapeutic target of acute generalized exanthematous pustulosis (AGEP)

J Allergy Clin Immunol Pract. 2020 Jun;8(6):2081-2084.e2. doi: 10.1016/j.jaip.2020.01.045. Epub 2020 Jan 31.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Generalized Exanthematous Pustulosis* / diagnosis
  • Humans
  • Interleukin-17

Substances

  • Interleukin-17